341 related articles for article (PubMed ID: 24548561)
1. The Angiomotins--from discovery to function.
Moleirinho S; Guerrant W; Kissil JL
FEBS Lett; 2014 Aug; 588(16):2693-703. PubMed ID: 24548561
[TBL] [Abstract][Full Text] [Related]
2. The role of Motin family proteins in tumorigenesis-an update.
Amirifar P; Kissil J
Oncogene; 2023 Apr; 42(16):1265-1271. PubMed ID: 36973516
[TBL] [Abstract][Full Text] [Related]
3. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
4. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.
Zeng H; Ortiz A; Shen PF; Cheng CJ; Lee YC; Yu G; Lin SC; Creighton CJ; Yu-Lee LY; Lin SH
Oncotarget; 2017 Feb; 8(6):10145-10160. PubMed ID: 28052036
[TBL] [Abstract][Full Text] [Related]
5. Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling.
Wang H; Lu B; Castillo J; Zhang Y; Yang Z; McAllister G; Lindeman A; Reece-Hoyes J; Tallarico J; Russ C; Hoffman G; Xu W; Schirle M; Cong F
J Biol Chem; 2016 Jul; 291(29):15256-66. PubMed ID: 27231341
[TBL] [Abstract][Full Text] [Related]
6. Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations.
Troilo A; Benson EK; Esposito D; Garibsingh RA; Reddy EP; Mungamuri SK; Aaronson SA
Oncotarget; 2016 May; 7(20):28765-82. PubMed ID: 27144834
[TBL] [Abstract][Full Text] [Related]
7. Angiomotins link F-actin architecture to Hippo pathway signaling.
Mana-Capelli S; Paramasivam M; Dutta S; McCollum D
Mol Biol Cell; 2014 May; 25(10):1676-85. PubMed ID: 24648494
[TBL] [Abstract][Full Text] [Related]
8. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway.
Li Y; Zhou H; Li F; Chan SW; Lin Z; Wei Z; Yang Z; Guo F; Lim CJ; Xing W; Shen Y; Hong W; Long J; Zhang M
Cell Res; 2015 Jul; 25(7):801-17. PubMed ID: 26045165
[TBL] [Abstract][Full Text] [Related]
9. Angiomotin family proteins in the Hippo signaling pathway.
Wang Y; Yu FX
Bioessays; 2024 May; ():e2400076. PubMed ID: 38760875
[TBL] [Abstract][Full Text] [Related]
10. Angiomotin functions in HIV-1 assembly and budding.
Mercenne G; Alam SL; Arii J; Lalonde MS; Sundquist WI
Elife; 2015 Jan; 4():. PubMed ID: 25633977
[TBL] [Abstract][Full Text] [Related]
11. Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.
Stalin J; Harhouri K; Hubert L; Subrini C; Lafitte D; Lissitzky JC; Elganfoud N; Robert S; Foucault-Bertaud A; Kaspi E; Sabatier F; Aurrand-Lions M; Bardin N; Holmgren L; Dignat-George F; Blot-Chabaud M
J Biol Chem; 2013 Mar; 288(13):8991-9000. PubMed ID: 23389031
[TBL] [Abstract][Full Text] [Related]
12. Protein diversity is generated within the motin family of proteins by alternative pre-mRNA splicing.
Moreau J; Lord M; Boucher M; Belleau P; Fernandes MJ
Gene; 2005 May; 350(2):137-48. PubMed ID: 15804419
[TBL] [Abstract][Full Text] [Related]
13. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
[TBL] [Abstract][Full Text] [Related]
14. p130-angiomotin associates to actin and controls endothelial cell shape.
Ernkvist M; Aase K; Ukomadu C; Wohlschlegel J; Blackman R; Veitonmäki N; Bratt A; Dutta A; Holmgren L
FEBS J; 2006 May; 273(9):2000-11. PubMed ID: 16640563
[TBL] [Abstract][Full Text] [Related]
15. Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation.
Chan SW; Lim CJ; Guo F; Tan I; Leung T; Hong W
J Biol Chem; 2013 Dec; 288(52):37296-307. PubMed ID: 24225952
[TBL] [Abstract][Full Text] [Related]
16. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis.
Dai X; She P; Chi F; Feng Y; Liu H; Jin D; Zhao Y; Guo X; Jiang D; Guan KL; Zhong TP; Zhao B
J Biol Chem; 2013 Nov; 288(47):34041-34051. PubMed ID: 24106267
[TBL] [Abstract][Full Text] [Related]
18. Regulation of localization and function of the transcriptional co-activator YAP by angiomotin.
Moleirinho S; Hoxha S; Mandati V; Curtale G; Troutman S; Ehmer U; Kissil JL
Elife; 2017 May; 6():. PubMed ID: 28464980
[TBL] [Abstract][Full Text] [Related]
19. RICH1 inhibits breast cancer stem cell traits through activating kinases cascade of Hippo signaling by competing with Merlin for binding to Amot-p80.
Tian Q; Gao H; Zhou Y; Zhu L; Yang J; Wang B; Liu P; Yang J
Cell Death Dis; 2022 Jan; 13(1):71. PubMed ID: 35064101
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles for angiomotin in the nervous system.
Wigerius M; Quinn D; Fawcett JP
Sci Signal; 2020 Oct; 13(655):. PubMed ID: 33109746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
